Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase-Deficient Heterozygotes - A Preliminary Report

Circulation

Volumn 94, Issue 12, 1996, Pages 3239-3245

  Sprecher, Dennis L ^a,b   Harris, Betsy V ^b   Stein, Evan A ^c   Bellet, Paul S ^d   Keilson, Leonard M ^e   Simbartl, Loretta A ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHRIST HOSPITAL   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e MAINE MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Genetics; Lipoproteins; Metabolism

Indexed keywords

AMINO ACID; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL HYPERLIPEMIA; FEMALE; GENE; HETEROZYGOTE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, LDL; EXONS; GLUTAMIC ACID; GLYCINE; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; ISOLEUCINE; LIPOPROTEIN LIPASE; POINT MUTATION; SYSTOLE; THREONINE; TRIGLYCERIDES; TRYPTOPHAN;

EID: 0030464749     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3239     Document Type: Article

References (46)

1. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52:1544-1568.
2. Friedlander Y, Kark JD, Stein Y. Complex segregation analysis of low levels of plasma high-density lipoprotein cholesterol in a sample of nuclear families in Jerusalem. Genet Epidemiol. 1986;3:285-297.
3. Third JLHC, Montag J, Flynn M, Freidel J, Laskarzewski PM, Glueck CJ. Primary and familial hypoalphalipoproteinemia. Metabolism. 1984;33:136-146.
4. Sprecher DL, Feigelson HS, Laskarzewski PM. The low HDL cholesterol/high triglyceride trait. Arterioscler Thromb. 1993;13:495-504.
5. Miesenböck G, Hölzl B, Föger B, Brandstätter E, Paulweber B, Sandhofer F, Patsch JR. Heterozygous lipoprotein lipase deficiency due to a missence mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 1993;91:448-455.
6. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495-506.
7. Wilson DE, Emi M, Iverius P-H, Hata A, Wu LL, Hillas E, Williams RR, Lalouel J-M. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest. 1990;86:735-750.
8. Babirak SP, Brown BG, Brunzell JD. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb. 1992;12:1176-1183.
9. Nikkila EA, Taskinen MR, Sane T. Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism. Am Heart J. 1987;113:543-548.
10. Breslow JL. Familial disorders of high density lipoprotein metabolism. In: Scriver CR, Beaudet A, Sly WS, and Valle D, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill; 1989:1251-1266.
11. Schaefer EJ, Levy RI, Anderson DW, Danner RN, Brewer HB Jr, Blackwelder WC. Plasma-triglycerides in regulation of HDL-cholesterol levels. Lancet. 1978;2:391-393.
12. Julien P, Gagne C, Yen Murthy M, Cantin B, Cadelis F, Moorjani S, Lupien P. Mutations of the lipoprotein lipase gene as a cause of dyslipidemias in the Quebec population. Can J Cardiol. 1994;10(suppl B):54B-60B.
13. Pimstone SN, Gagne ES, Gagne C, Lupien PJ, Gaudet D, Williams RR, Kotze M, Reymer PWA, Defesche JC, Kastelein JJP, Moorjani S, Hayden MR. Mutations in the gene for lipoprotein lipase: a cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995;15:1704-1712.
14. Reymer P, Gagne E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H, Seidell JC, Kromhout D, Lie KE, Kastelein J, Hayden MR. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet. 1995;10:28-34.
15. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou J-P, Bard J-M, Fruchart J-C, Apfelbaum M, Cambien F, Tiret L. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res. 1995;36:2141-2146.
16. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet A, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill; 1995:1913-1932.
17. 64→ nonsense mutation in the lipoprotein lipase gene. J Lipid Res. 1992;33:859-866.
18. Myers GL, Cooper GR, Winn CL, Smith SJ. The Centers for Disease Control National Heart, Lung and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin Lab Med. 1989;9:105-135.
19. Steiner PM, Freidel J, Bremner WF, Stein EA. Standardization of micro-methods for plasma cholesterol, triglyceride, and HDL-cholesterol with the Lipid Research Clinics' methodology. J Clin Chem Clin Biochem. 1981;19:850A.
20. Stein EA, DiPersio L, Pesce AJ, Kashyap ML, Kao J-T, Srivastava L, McNerney C. Enzyme-linked immunoabsorbent assay of apolipoprotein A-II in plasma with use of a monoclonal antibody. Clin Chem. 1986;32:967-971.
21. Young SG, Smith RS, Hogle DM, Curtiss LK, Witztum JL. Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin Chem. 1986;32:1484-1490.
22. Hogle DM, Smith RS, Curtiss LK. Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay. J Lipid Res. 1988;29:1221-1229.
23. Hainline A, Karon J, Lippel K, eds. Lipid Research Clinics Program: Manual of Laboratory Operations. Lipid and Lipoprotein Analysis. Bethesda, Md: National Heart, Lung, and Blood Institute, US Government Printing Office. No. 1982-361-132:678/HEW publication No. NIH 75-628 (revised); 1982.
24. Ameis D, Kobayashi J, Davis RC, Ben-Zeev O, Malloy MJ, Kane JP, Lee G, Wong H, Havel RJ, Schotz MC. Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene. J Clin Invest. 1991;87:1165-1170.
25. Henderson HE, Devlin R, Peterson J, Brunzell JD, Hayden MR. Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency. Mol Biol Med. 1990;7:511-517.
26. Scharf SJ, Horn GT, Erlich HA. Direct cloning and sequence analysis of enzymatically amplified genomic sequences. Science. 1986;233:1076-1078.
27. SAS Institute Inc. SAS User's Guide: Statistics. 5th ed. Cary, NC: SAS Institute, Inc; 1985.
28. Polonsky SM, Simbartl LA, Sprecher DL. Triglyceride and high density lipoprotein cholesterol: predicting disorders in parents from their children. Pediatrics. 1994;94:824-831.
29. Julien P, Gagne C, Murthy MRV, Moorjani S, Brunzell JD, Hayden MR, Lupien PJ. Plasma lipoproteins and lipoprotein lipase in French Canadians heterozygous for missense mutation in the lipoprotein lipase gene. Circulation. 1992;86(suppl I):I-419. Abstract.
30. Wilson DE, Hata A, Kwong LK, Lingam A, Shuhua J, Ridinger DN, Yeager C, Kaltenborn KC, Iverius P-H, Lalouel J-M. Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes. J Clin Invest. 1993;92:203-211.
31. Stalenhoef AFH, Armstrong VW, Steinmetz A, Taskinen M-R, Zechner R. The 17th Annual Meeting of the European Lipoprotein Club. Arterioscler Thromb Vasc Biol. 1995;15:543-549.
32. Julien P, Normand T, Bergeron J, Yen Murthy MR, Dionne C, De Braekleer M, Gagne C, Brunzell JD, Hayden MR, Lupien PJ. Prevalence and origin of familial lipoprotein lipase deficiency in the French-Canadian population of Quebec. Arterioscler Thromb. 1991;11:1416A.
33. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apo A-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size: effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb. 1994;14:707-720.
34. Hata A, Ridinger DN, Sutherland SD, Emi M, Kwong LK, Shuhua J, Lubbers A, Guy-Grand B, Basdevant B, Iverius P-H, Wilson DE, Lalouel J-M. Missense mutations in exon 5 of the human lipoprotein lipase gene: inactivation correlates with loss of dimerization. J Biol Chem. 1992;267:20132-20139.
35. Ma Y, Bruin T, Tuzgol S, Wilson BI, Roederer G, Liu M-S, Davignon J, Kastelein JJP, Brunzell JD, Hayden MR. Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. J Biol Chem. 1992;267:1918-1923.
36. 447→Ter) in a Turkish family. J Biol Chem. 1991;266:14418-14424.
37. Krapp A, Zhang H, Ginzinger D, Liu M-S, Lindberg A, Olivecrona G, Hayden MR, Beisiegel U. Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells. J Lipid Res. 1995;36:2362-2373.
38. Williams SE, Inoue I, Tran H, Fry GL, Pladet MW, Iverius PH, Lalouel JM, Chappell DA, Strickland DK. The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. J Biol Chem. 1994;269:8653-8658.
39. 2-macroglobulin receptor in vitro. J Biol Chem. 1993;268:14168-14173.
40. Gagne E, Genest J Jr, Zhang H, Clarke LA, Hayden MR. Analysis of DNA changes in the LpL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb. 1994;14:1250-1257.
41. Williams RR, Hopkins PN, Hunt SC, Schumacher MC, Elbein SC, Wilson DE, Stults BM, Wu LL, Hasstedt SJ, Lalouel JM. Familial dyslipidaemic hypertension and other multiple metabolic syndromes. Ann Med. 1992;24:469-475.
42. Wu D-A, Bu X, Jeng C-Y, Sheu WHH, Warden CH, Katsuya T, Dzau VJ, Reaven GM, Lusis AJ, Chen Y-DI, Rotter JI. Evidence for linkage of blood pressure to the lipoprotein lipase and glucose transporter 2 loci: genetic support for syndrome x. Circulation. 1994;90(suppl I):I-129. Abstract.
43. Reaven GM. The role of insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism. 1992;41(suppl 1):16-19.
44. Renier G, Lambert A. Lipoprotein lipase synergizes with Interferon gamma to induce macrophage nitric oxide synthetase mRNA expression and nitric acid production. Arteriuscler Thromb Vasc Biol. 1995;15:392-399.
45. Babirak SP, Iverius P-H, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis. 1989;9:326-334.
46. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipid. 1995;6:291-305.